Navigation Links
Celleration, Inc. Announces Close of $8 Million Series E Financing
Date:1/11/2011

EDEN PRAIRIE, Minn., Jan. 11, 2011 /PRNewswire/ -- Celleration, Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound products, today announced the closing of an $8 million Series E round of equity financing.  All of the Company's existing institutional investors participated in this round in addition to Sightline Healthcare Opportunity Fund who participated as a new investor.

"The addition of Sightline Healthcare Opportunity Fund as a new investor to our solid base of venture capital partners is a strong endorsement of the team we have built and further validates the potential value of MIST Therapy to all stakeholders in today's cost sensitive healthcare environment," said Mark Wagner, President and CEO of Celleration, Inc.  "This round of financing positions Celleration well for the next phase of growth and market development and provides funding to develop additional applications for MIST Therapy."

About Celleration, Inc.:

Celleration, Inc. is a privately held medical device company. Celleration develops and markets a proprietary technology that has been proven to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface.  Celleration's core product, the MIST Therapy® System has been clinically shown to positively impact all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating non-healing wounds.  Currently, over 45,000 patients have been treated with 800 system installations.


'/>"/>
SOURCE Celleration, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RF Technologies® Announces Distributor Agreement With Universal Hospital Services
2. Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions
3. Dehaier Medical Announces Participation in Arab Health 2011
4. CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business
5. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
6. Stereotaxis Announces CE Mark and First Human Case for Vdrive™
7. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
8. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
9. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
10. Nalco Announces Price Increase
11. Vasomedical Announces Launch of Its Online Company Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
Breaking Medicine News(10 mins):